Principles of immunisation in children with solid organ transplant.
Adolescent
Child
Child, Preschool
Family Characteristics
Humans
Immunization
/ methods
Immunosuppressive Agents
/ adverse effects
Organ Transplantation
/ adverse effects
Post-Exposure Prophylaxis
/ methods
Transplant Recipients
/ education
Transplantation Immunology
/ immunology
Travel
Vaccine-Preventable Diseases
/ complications
Vaccines
/ standards
epidemiology
therapeutics
virology
Journal
Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
03
06
2020
revised:
10
08
2020
accepted:
10
08
2020
pubmed:
18
9
2020
medline:
26
3
2021
entrez:
17
9
2020
Statut:
ppublish
Résumé
Vaccine-preventable diseases (VPD) are a significant risk to paediatric solid organ transplant (SOT) recipients on lifelong immunosuppressive therapy. Children progressing to end-stage organ dysfunction are unable to mount a robust immune response. Hence, it is important to plan vaccination early in the course of disease, especially if a child is anticipated to be a SOT candidate. Vaccine recommendations need to be individualised in this population based on vaccine history and serology. Catch-up or accelerated schedules may be used to complete vaccinations before transplant. Post-transplant, immunisation is recommenced in consultation with the transplant team taking into context the time since transplant and the intensity of the immunosuppressive regime. Inactivated vaccines are safe post-transplant but postexposure prophylaxis may still be required in children with inadequate immunity to VPD. Specific vaccines may be advised for SOT recipients travelling abroad (in consultation with a travel clinic) or those entering high-risk professions. Additionally, the vaccination status of all household members and close contacts should be reviewed and optimised, offering additional protection to the transplant recipient.
Identifiants
pubmed: 32938624
pii: archdischild-2020-319822
doi: 10.1136/archdischild-2020-319822
doi:
Substances chimiques
Immunosuppressive Agents
0
Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
219-223Informations de copyright
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.